论文部分内容阅读
二氟尼柳(diflunisal)系非甾体抗炎镇痛药,临床上用于治疗风湿性关节炎、类风湿关节炎、骨关节炎、扭伤、劳损和镇痛。二氟尼柳是美国MerckSharpDohme公司以氟尼柳(flunisal)为先导化合物,从500多个水杨酸衍生物中筛选出来的,于1975年上市。目前是默克公司年销售额超1亿美元的
Diflunisal is a nonsteroidal antiinflammatory and analgesic for the clinical use in the treatment of rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, sprains, strain and pain relief. Diflunisal is the United States MerckSharpDohme company to flunisal (flunisal) as the lead compound, from more than 500 salicylic acid derivatives out of the market in 1975. Merck currently has over $ 100 million in annual sales